150 related articles for article (PubMed ID: 2859021)
1. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
Mallya RK; Hind CR; Berry H; Pepys MB
Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Pountain GD; Calvin J; Hazleman BL
Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
5. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
6. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
Hachulla E; Laine A; Hayem A
Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
8. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
Papadakis MA; Schwartz ND
Arch Intern Med; 1986 Nov; 146(11):2283-4. PubMed ID: 3778060
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Repeated measurements of erythrocyte sedimentation rate are not efficient use of time or resources.
Roome P
BMJ; 1997 Aug; 315(7107):550. PubMed ID: 9329329
[No Abstract] [Full Text] [Related]
11. CRP in the management of polymyalgia rheumatica and giant cell arteritis.
Schreiber S
Clin Rheumatol; 1987 Mar; 6(1):97-8. PubMed ID: 3581706
[No Abstract] [Full Text] [Related]
12. The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica.
Schreiber S; Buyse M
Clin Rheumatol; 1995 May; 14(3):315-8. PubMed ID: 7641508
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica.
Shimojima Y; Matsuda M; Gono T; Ishii W; Ikeda S
Intern Med; 2005 Sep; 44(9):1009-12. PubMed ID: 16258224
[TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
17. Delayed onset of polymyalgia in polymyalgia rheumatica.
Greenstone M; Shaw AB
Br J Rheumatol; 1986 Feb; 25(1):82-4. PubMed ID: 3942849
[TBL] [Abstract][Full Text] [Related]
18. Frequency of a normal erythrocyte sedimentation rate in patients with active, untreated arteritis temporalis and polymyalgia rheumatica: comment on the article by Helfgott and Kieval.
Olsson AT; Elling H; Elling P
Arthritis Rheum; 1997 Jan; 40(1):191-3. PubMed ID: 9008618
[No Abstract] [Full Text] [Related]
19. Alkaline phosphatase and gamma-glutamyltransferase in polymyalgia rheumatica and giant cell arteritis.
Sheehan NJ
Ann Rheum Dis; 1985 Sep; 44(9):644-5. PubMed ID: 2864020
[No Abstract] [Full Text] [Related]
20. [C-reactive protein or blood sedimentation reaction os preventive studies in the physician's laboratory?].
Steiner A; Vetter W
Ther Umsch; 1995 May; 52(5):350-4. PubMed ID: 7770822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
